Farmacosmo SpA (MIL:COSMO) EBIT: €-2.29 Mil (TTM As of Dec. 2025)


MIL:COSMO Farmacosmo SpA MIL:COSMO
33 GF Score
Price €0.50
GF Value €0.73
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Farmacosmo SpA EBIT?

Farmacosmo SpA MIL:COSMO -0.79% 33 EBIT is €-2.29 Mil as of Dec. 2025. GuruFocus rates MIL:COSMO with a GF Score™ of 33/100 and a GF Value™ of €0.73 (Possible Value Trap). The stock has 5 warning signs investors should review.

Farmacosmo SpA's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €-0.20 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.29 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Farmacosmo SpA's annualized ROC % for the quarter that ended in Dec. 2025 was -45.57%. Farmacosmo SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -161.77%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Farmacosmo SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -8.85%.

Farmacosmo SpA  (MIL:COSMO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Farmacosmo SpA's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-6.982 * ( 1 - 0% )/( (12.059 + 18.584)/ 2 )
=-6.982/15.3215
=-45.57 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=28.551 - 19.766 - ( 2.006 - max(0, 20.058 - 16.784+2.006))
=12.059

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=28.082 - 13.793 - ( 0.947 - max(0, 20.182 - 15.887+0.947))
=18.584

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Farmacosmo SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.402/( ( (0.265 + max(-5.91, 0)) + (0.232 + max(-6.453, 0)) )/ 2 )
=-0.402/( ( 0.265 + 0.232 )/ 2 )
=-0.402/0.2485
=-161.77 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.678 + 9.931 + 1.539) - (19.766 + 0 + 0.292)
=-5.91

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.58 + 4.871 + 1.152) - (13.793 + 0 + 0.263)
=-6.453

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Farmacosmo SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-2.294/25.930
=-8.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmacosmo SpA EBIT Related Terms

Farmacosmo SpA EBIT Historical Data

* Premium members only.

The historical data trend for Farmacosmo SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmacosmo SpA EBIT Chart

Farmacosmo SpA Annual Data
Trend Dec19 Dec20 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 0.52 -1.61 -3.23 -1.90 -2.29

Farmacosmo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1.70 -0.61 -1.30 -2.09 -0.20

Farmacosmo SpA EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Farmacosmo SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farmacosmo SpA EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Farmacosmo SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Farmacosmo SpA's EV-to-EBIT falls into.


MIL:COSMO
33GF Score
Farmacosmo SpA MIL:COSMO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Farmacosmo SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-2.29 Mil mean?
Farmacosmo SpA (MIL:COSMO) has a EBIT of €-2.29 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Farmacosmo SpA.
Is Farmacosmo SpA's EBIT too high?
Farmacosmo SpA's current EBIT is €-2.29 Mil. Overall, Farmacosmo SpA has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Farmacosmo SpA's EBIT compare to competitors?
Farmacosmo SpA's EBIT of €-2.29 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Farmacosmo SpA. Farmacosmo SpA's current EBIT is €-2.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmacosmo SpA stock overvalued right now?
Based on GuruFocus' analysis, Farmacosmo SpA (MIL:COSMO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.73, compared to a current price of €0.50 — trading 31.2% below its estimated fair value. The current EBIT is €-2.29 Mil. Farmacosmo SpA's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Farmacosmo SpA (MIL:COSMO), the current EBIT is €-2.29 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Farmacosmo SpA (MIL:COSMO) Overvalued in 2026?

Based on GuruFocus' analysis, Farmacosmo SpA stock appears to be undervalued. The current stock price of €0.50 is trading 31.2% below its estimated GF Value™ of €0.73. GuruFocus considers Farmacosmo SpA to be Possible Value Trap.

Key valuation signals for MIL:COSMO:

  • EBIT: €-2.29 Mil
  • GF Value™: €0.73 vs. price of €0.50 (31.2% below fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the MIL:COSMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Farmacosmo SpA Business Description

Address Via Crispi, Number 51, Napoli, ITA, IT-80121
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
33GF Score

Get the complete analysis for MIL:COSMO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price
€0.73
GF Value